Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-010694

Senior VP - Drug Discovery gave up 21,125 shares (to pay taxes)

  • Senior VP - Drug Discovery acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Senior VP - Drug Discovery

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-06 Exercise or conversion : show line 1 in the form +20,622 $3.26 $67,228 120,618 D
2018-03-06 Shares withheld for taxes : show line 2 in the form −15,223 $5.18 $78,855 105,395 D
2018-03-06 Exercise or conversion : show line 3 in the form +9,378 $3.26 $30,572 114,773 D
2018-03-06 Shares withheld for taxes : show line 4 in the form −5,902 $5.18 $30,572 108,871 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-03-06 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option −20,622 0 D
2018-03-06 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −9,378 0 D
Loading xslF345X03/form4.xml…